Carregant...
Cardiovascular Safety and Superiority of Anti-Obesity Medications
Over the past few decades, several anti-obesity medications have demonstrated an association with adverse cardiovascular outcomes, leading to their market withdrawal. This has caused researchers to investigate the cardiovascular safety of such medications in cardiovascular outcome trials. However, t...
Guardat en:
| Publicat a: | Diabetes Metab Syndr Obes |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286099/ https://ncbi.nlm.nih.gov/pubmed/34285527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S311359 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|